In the present study, we aimed to clarify the effects of aberrant FSTL1 expression on the growth and aggressiveness of RCC cells, identify the signaling pathways that were affected by FSTL1, and validate the prognostic functions of FSTL1 with a cohort of RCC patients. Here, FSTL1 is linked to renal cell carcinoma.